Distinct subpopulations of DN1 thymocytes exhibit preferential γδ T lineage potential

Front Immunol. 2023 Apr 3:14:1106652. doi: 10.3389/fimmu.2023.1106652. eCollection 2023.

Abstract

The αβ and γδ T cell lineages both differentiate in the thymus from common uncommitted progenitors. The earliest stage of T cell development is known as CD4-CD8- double negative 1 (DN1), which has previously been shown to be a heterogenous mixture of cells. Of these, only the CD117+ fraction has been proposed to be true T cell progenitors that progress to the DN2 and DN3 thymocyte stages, at which point the development of the αβ and γδ T cell lineages diverge. However, recently, it has been shown that at least some γδ T cells may be derived from a subset of CD117- DN thymocytes. Along with other ambiguities, this suggests that T cell development may not be as straightforward as previously thought. To better understand early T cell development, particularly the heterogeneity of DN1 thymocytes, we performed a single cell RNA sequence (scRNAseq) of mouse DN and γδ thymocytes and show that the various DN stages indeed comprise a transcriptionally diverse subpopulations of cells. We also show that multiple subpopulations of DN1 thymocytes exhibit preferential development towards the γδ lineage. Furthermore, specific γδ-primed DN1 subpopulations preferentially develop into IL-17 or IFNγ-producing γδ T cells. We show that DN1 subpopulations that only give rise to IL-17-producing γδ T cells already express many of the transcription factors associated with type 17 immune cell responses, while the DN1 subpopulations that can give rise to IFNγ-producing γδ T cell already express transcription factors associated with type 1 immune cell responses.

Keywords: T cell development; gamma delta (γδ) T cells; lineage decision; scRNAseq; thymocyte.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation
  • Interleukin-17* / metabolism
  • Mice
  • Thymocytes*
  • Thymus Gland
  • Transcription Factors / metabolism

Substances

  • Interleukin-17
  • Transcription Factors

Grants and funding

This work was supported by grants and fellowships from the National Health and Medical Research Council, Australia (1078763, 1090236, 1145888, and 1158024 to DG and 1079586, 1117154, 1122384, and 1122395 to MC), Cancer Council Victoria (1102104 to DG), Diabetes Australia (Y20G-CHOM to MC), and U.S. Department of Defense (W81XWH-19-1-0728 to MC) and the Victorian State Government Operational Infrastructure Support and the Independent Research Institutes Infrastructure Support Scheme of the National Health and Medical Research Council, Australia.